MXPA05006925A - Derivados de benzamida novedosos y proceso para producir los mismos. - Google Patents

Derivados de benzamida novedosos y proceso para producir los mismos.

Info

Publication number
MXPA05006925A
MXPA05006925A MXPA05006925A MXPA05006925A MXPA05006925A MX PA05006925 A MXPA05006925 A MX PA05006925A MX PA05006925 A MXPA05006925 A MX PA05006925A MX PA05006925 A MXPA05006925 A MX PA05006925A MX PA05006925 A MXPA05006925 A MX PA05006925A
Authority
MX
Mexico
Prior art keywords
production
benzamide derivatives
novel benzamide
novel
derivatives
Prior art date
Application number
MXPA05006925A
Other languages
English (en)
Inventor
Kakefuda Akio
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of MXPA05006925A publication Critical patent/MXPA05006925A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Se proporciona un proceso novedoso para la produccion de un derivado de isoquinolina que tiene una accion inhibidora para la corriente l un derivado de benzamida novedoso o una sal del mismo que se utiliza para el proceso de produccion; y un proceso para la produccion del derivado de benzamida o una sal del mismo.
MXPA05006925A 2002-12-25 2003-12-24 Derivados de benzamida novedosos y proceso para producir los mismos. MXPA05006925A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002375153 2002-12-25
PCT/JP2003/016582 WO2004058710A1 (ja) 2002-12-25 2003-12-24 新規ベンズアミド誘導体及びその製造法

Publications (1)

Publication Number Publication Date
MXPA05006925A true MXPA05006925A (es) 2005-12-12

Family

ID=32677328

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05006925A MXPA05006925A (es) 2002-12-25 2003-12-24 Derivados de benzamida novedosos y proceso para producir los mismos.

Country Status (8)

Country Link
US (1) US20060084807A1 (es)
JP (1) JPWO2004058710A1 (es)
KR (1) KR100758522B1 (es)
CN (1) CN1753870A (es)
AU (1) AU2003292757A1 (es)
CA (1) CA2511989A1 (es)
MX (1) MXPA05006925A (es)
WO (1) WO2004058710A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007023775A1 (ja) * 2005-08-23 2007-03-01 Astellas Pharma Inc. 心房細動治療剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02138172A (ja) * 1988-11-19 1990-05-28 Mitsubishi Kasei Corp β−アミノ酸アミド誘導体
ATE262518T1 (de) * 1999-06-03 2004-04-15 Yamanouchi Pharma Co Ltd Neuartige isoquinolin-derivate oder salze davon

Also Published As

Publication number Publication date
WO2004058710A1 (ja) 2004-07-15
AU2003292757A1 (en) 2004-07-22
CA2511989A1 (en) 2004-07-15
US20060084807A1 (en) 2006-04-20
CN1753870A (zh) 2006-03-29
KR20050086940A (ko) 2005-08-30
JPWO2004058710A1 (ja) 2006-04-27
KR100758522B1 (ko) 2007-09-14

Similar Documents

Publication Publication Date Title
RS86804A (en) Quinoline and isoquinoline derivatives method for the production thereof and use therof as anti-inflammatory agents
HUP0101616A3 (en) Substituted benzamides, their production and their use as cysteine protease inhibitors
IS6069A (is) N-cýanómetýlamíð sem próteasalatar
IL165434A0 (en) Compounds having DPP-IV inhibitory activity
DE60236102D1 (en) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
EP1575486A4 (en) METHOD AND COMPOSITION FOR IDENTIFYING THERAPEUTIC ANTI-HIV MEDIUM
IL156096A0 (en) New mandelic acid derivatives and their use as thrombin inhibitors
YU2003A (sh) Stabilne soli o-acetilsalicilne kiseline sa baznim amino-kiselinama
MXPA03009548A (es) Arilsulfonamidas como agentes antivirales.
WO2001068645A3 (en) N-cyanomethylcarboxamides and their use as protease inhibitors
PT1501804E (pt) Derivados de isoquinolina
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
WO2003076391A3 (de) Hemmstoffe der urokinase, ihre herstellung und verwendung
AU2003244727A1 (en) Novel podophyllotoxin derivatives, the production thereof and the use of the same in therapeutics
AU2003208159A1 (en) Support for appliances to be worn on the head
USD462389S1 (en) Teaching aid for learning to tell time
MXPA05006925A (es) Derivados de benzamida novedosos y proceso para producir los mismos.
HK1063627A1 (en) New mandelic acid derivative and its use as thrombin inhibitors
DE60216142D1 (de) Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen
MY139289A (en) Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
HK1075885A1 (en) 20-Hydroxyeicosatetraenoic acid production inhibitors
BG105252A (en) Isoquinolines as urokinase inhibitors
MXPA03002047A (es) Fenilciclohexanocarboxamidas substituidas y su uso.
AU2003301260A1 (en) Novel methods for the production of cloned mammals, mammals cloned according to the methods, and methods of use of same
DK1220844T3 (da) Arylsulfonamid-substituerede benzimidazolderivater og deres anvendelse som tryptase-inhibitorer